242 related articles for article (PubMed ID: 11274365)
1. PTEN controls tumor-induced angiogenesis.
Wen S; Stolarov J; Myers MP; Su JD; Wigler MH; Tonks NK; Durden DL
Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4622-7. PubMed ID: 11274365
[TBL] [Abstract][Full Text] [Related]
2. PTEN and phosphatidylinositol 3'-kinase inhibitors up-regulate p53 and block tumor-induced angiogenesis: evidence for an effect on the tumor and endothelial compartment.
Su JD; Mayo LD; Donner DB; Durden DL
Cancer Res; 2003 Jul; 63(13):3585-92. PubMed ID: 12839945
[TBL] [Abstract][Full Text] [Related]
3. MMAC/PTEN tumor suppressor gene regulates vascular endothelial growth factor-mediated angiogenesis in prostate cancer.
Koul D; Shen R; Garyali A; Ke LD; Liu TJ; Yung WK
Int J Oncol; 2002 Sep; 21(3):469-75. PubMed ID: 12168088
[TBL] [Abstract][Full Text] [Related]
4. PTEN gene transfer in human malignant glioma: sensitization to irradiation and CD95L-induced apoptosis.
Wick W; Furnari FB; Naumann U; Cavenee WK; Weller M
Oncogene; 1999 Jul; 18(27):3936-43. PubMed ID: 10435616
[TBL] [Abstract][Full Text] [Related]
5. PTEN decreases in vivo vascularization of experimental gliomas in spite of proangiogenic stimuli.
Abe T; Terada K; Wakimoto H; Inoue R; Tyminski E; Bookstein R; Basilion JP; Chiocca EA
Cancer Res; 2003 May; 63(9):2300-5. PubMed ID: 12727853
[TBL] [Abstract][Full Text] [Related]
6. PTEN can inhibit in vitro organotypic and in vivo orthotopic invasion of human bladder cancer cells even in the absence of its lipid phosphatase activity.
Gildea JJ; Herlevsen M; Harding MA; Gulding KM; Moskaluk CA; Frierson HF; Theodorescu D
Oncogene; 2004 Sep; 23(40):6788-97. PubMed ID: 15273733
[TBL] [Abstract][Full Text] [Related]
7. Pten signaling in gliomas.
Knobbe CB; Merlo A; Reifenberger G
Neuro Oncol; 2002 Jul; 4(3):196-211. PubMed ID: 12084351
[TBL] [Abstract][Full Text] [Related]
8. Motif analysis of the tumor suppressor gene MMAC/PTEN identifies tyrosines critical for tumor suppression and lipid phosphatase activity.
Koul D; Jasser SA; Lu Y; Davies MA; Shen R; Shi Y; Mills GB; Yung WK
Oncogene; 2002 Apr; 21(15):2357-64. PubMed ID: 11948419
[TBL] [Abstract][Full Text] [Related]
9. The PTEN lipid phosphatase domain is not required to inhibit invasion of glioma cells.
Maier D; Jones G; Li X; Schönthal AH; Gratzl O; Van Meir EG; Merlo A
Cancer Res; 1999 Nov; 59(21):5479-82. PubMed ID: 10554022
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of the PTEN tumor suppressor gene is associated with increased angiogenesis in clinically localized prostate carcinoma.
Giri D; Ittmann M
Hum Pathol; 1999 Apr; 30(4):419-24. PubMed ID: 10208463
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growth.
Edwards LA; Thiessen B; Dragowska WH; Daynard T; Bally MB; Dedhar S
Oncogene; 2005 May; 24(22):3596-605. PubMed ID: 15782140
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus-mediated transfer of the PTEN gene inhibits human colorectal cancer growth in vitro and in vivo.
Saito Y; Swanson X; Mhashilkar AM; Oida Y; Schrock R; Branch CD; Chada S; Zumstein L; Ramesh R
Gene Ther; 2003 Nov; 10(23):1961-9. PubMed ID: 14528320
[TBL] [Abstract][Full Text] [Related]
13. The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells.
Furnari FB; Huang HJ; Cavenee WK
Cancer Res; 1998 Nov; 58(22):5002-8. PubMed ID: 9823298
[TBL] [Abstract][Full Text] [Related]
14. In vivo gene therapy of human bladder cancer with PTEN suppresses tumor growth, downregulates phosphorylated Akt, and increases sensitivity to doxorubicin.
Tanaka M; Grossman HB
Gene Ther; 2003 Sep; 10(19):1636-42. PubMed ID: 12923562
[TBL] [Abstract][Full Text] [Related]
15. PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death.
Weng LP; Smith WM; Dahia PL; Ziebold U; Gil E; Lees JA; Eng C
Cancer Res; 1999 Nov; 59(22):5808-14. PubMed ID: 10582703
[TBL] [Abstract][Full Text] [Related]
16. Cell cycle arrest by the PTEN tumor suppressor is target cell specific and may require protein phosphatase activity.
Hlobilkova A; Guldberg P; Thullberg M; Zeuthen J; Lukas J; Bartek J
Exp Cell Res; 2000 May; 256(2):571-7. PubMed ID: 10772829
[TBL] [Abstract][Full Text] [Related]
17. Differential SKIP expression in PTEN-deficient glioblastoma regulates cellular proliferation and migration.
Davies EM; Kong AM; Tan A; Gurung R; Sriratana A; Bukczynska PE; Ooms LM; McLean CA; Tiganis T; Mitchell CA
Oncogene; 2015 Jul; 34(28):3711-27. PubMed ID: 25241900
[TBL] [Abstract][Full Text] [Related]
18. Adenoviral-mediated expression of MMAC/PTEN inhibits proliferation and metastasis of human prostate cancer cells.
Davies MA; Kim SJ; Parikh NU; Dong Z; Bucana CD; Gallick GE
Clin Cancer Res; 2002 Jun; 8(6):1904-14. PubMed ID: 12060635
[TBL] [Abstract][Full Text] [Related]
19. Regulation of phosphoinositide metabolism, Akt phosphorylation, and glucose transport by PTEN (phosphatase and tensin homolog deleted on chromosome 10) in 3T3-L1 adipocytes.
Ono H; Katagiri H; Funaki M; Anai M; Inukai K; Fukushima Y; Sakoda H; Ogihara T; Onishi Y; Fujishiro M; Kikuchi M; Oka Y; Asano T
Mol Endocrinol; 2001 Aug; 15(8):1411-22. PubMed ID: 11463863
[TBL] [Abstract][Full Text] [Related]
20. Growth inhibition of human malignant glioma cells induced by the PI3-K-specific inhibitor.
Shingu T; Yamada K; Hara N; Moritake K; Osago H; Terashima M; Uemura T; Yamasaki T; Tsuchiya M
J Neurosurg; 2003 Jan; 98(1):154-61. PubMed ID: 12546364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]